LeMaitre Vascular【LMAT】銘柄情報

LeMaitre Vascular Inc (LMAT) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

94.48

( 0.98% )

買値

93.88

売値

107.00

出来高

244,038

93.34 日の範囲 95.34

79.005 52 週間の範囲 118.01

時価総額

2.159B

前日終値

93.56

始値

93.57

時刻

4143

94.48

(priorref)

最終取引時間

財務取引量

US$ 23,087,637

VWAP

94.6067

平均取引量 (3 か月)

US$ 251,410

発行済株式数

22,850,739

配当利回り

0.85 (0.93%)

PER

33.61

1 株当たり利益 (EPS)

2.72

歳入

256.28M

純利益

62.4M

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstru... LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.lemaitre.com

本社

Burlington, United States

設立

1983

LeMaitre Vascular Inc is listed in the Healthcare sector of the ナスダック市場 with ticker LMAT. The last closing price for LeMaitre Vascular was US$93.56. Over the last year, LeMaitre Vascular shares have traded in a share price range of US$ 79.005 to US$ 118.01.

LeMaitre Vascular currently has 22,850,739 shares in issue. The market capitalisation of LeMaitre Vascular is US$2.16 billion. LeMaitre Vascular has a price to earnings ratio (PE ratio) of 33.61.

Form 4 - Statement of changes in beneficial ownership of securities

Form SD - Specialized disclosure report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.12	-0.126849894292	94.6	96.47	90.28	311727	92.9803011	CS
4	-13.52	-12.5185185185	108	109.73	90.28	315896	97.69770558	CS
12	-13.22	-12.2748375116	107.7	118.01	90.28	247000	105.28850873	CS
26	8.36	9.70738504412	86.12	118.01	79.395	209770	99.7651146	CS
52	11.96	14.4934561318	82.52	118.01	79.005	185849	94.62893745	CS
156	30	46.5260545906	64.48	118.01	44.27	158487	83.94346198	CS
260	43.39	84.9285574476	51.09	118.01	38.32	138576	73.50290241	CS